[Crystepin T (Trimecryton). Multi-center evaluation of a anti-hypertensive agent containing a beta blocker].
D000328:Adult; D000368:Aged; D002752:Chlorthalidone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D054833:Isoindoles; D008297:Male; D014290:Metipranolol / Q000627:therapeutic use*; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*
D004338:Drug Combinations; D054833:Isoindoles; D011412:Propanolamines; C038903:chlorthalidone, dihydroergocristine mesilate, metipranolol drug combination; D004088:Dihydroergotoxine; D002752:Chlorthalidone; D014290:Metipranolol
Crystepin T (Trimecryton). Multicentrické hodnocení antihypertenzíva s obsahem beta-blokátoru.